Study sheds light on angiogenesis inhibitors, points to limitations, solutions

A new generation of cancer drugs designed to starve tumors of their blood supply - called "angiogenesis inhibitors"--succeeds at first, but then promotes more invasive cancer growth—sometimes with a higher incidence of metastases, according to a new study in animals. The research clarifies similar findings in other animal studies and is consistent with some early evidence from a small number of clinical trials with cancer patients.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news155226687.html">Study sheds light on angiogenesis inhibitors, points to limitations, solutions</a></p> <p>A new generation of cancer drugs designed to starve tumors of their blood supply - called "angiogenesis inhibitors"--succeeds at first, but then promotes more invasive cancer growth—sometimes with a higher incidence of metastases, according to a new study in animals. The research clarifies similar findings in other animal studies and is consistent with some early evidence from a small number of clinical trials with cancer patients.</p>